From the Food and Drug Administration.
Crawford
Lester M
LM
US Food and Drug Administration, USA.
D001688:Biological Products / Q000627:therapeutic use*; D001798:Blood Proteins / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D019992:Databases as Topic; D004869:Equipment Safety; D004864:Equipment and Supplies / Q000009:adverse effects*; D006801:Humans; D008113:Liver Neoplasms / Q000532:radiotherapy*; D008863:Microspheres; D019736:Prostheses and Implants; D019275:Radiopharmaceuticals / Q000008:administration & dosage*; D014481:United States; D014486:United States Food and Drug Administration; D015021:Yttrium Radioisotopes / Q000008:administration & dosage*
D001688:Biological Products; D001798:Blood Proteins; D019275:Radiopharmaceuticals; D015021:Yttrium Radioisotopes